Novartis Aktie
102,90
EUR
+3,38
EUR
+3,40
%
97,35
CHF
+3,55
CHF
+3,78
%
Werbung
Novartis Aktie Analyse
| 19.01.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 13.01.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 04.01.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 27.11.20 | Novartis Underweight | Barclays Capital | |
| 10.11.20 | Novartis Underweight | JP Morgan Chase & Co. | |
| 27.10.20 | Novartis Underweight | JP Morgan Chase & Co. | |
| 27.10.20 | Novartis Underweight | Barclays Capital | |
| 09.10.20 | Novartis Underweight | JP Morgan Chase & Co. | |
|
Werbung
|
|||
| 23.09.20 | Novartis Underweight | Barclays Capital | |
| 18.08.20 | Novartis Underweight | JP Morgan Chase & Co. | |
| 12.08.20 | Novartis Underweight | JP Morgan Chase & Co. | |
| 21.07.20 | Novartis Underweight | JP Morgan Chase & Co. | |
| 17.07.20 | Novartis Underweight | JP Morgan Chase & Co. | |
| 08.05.20 | Novartis Underweight | JP Morgan Chase & Co. | |
| 29.04.20 | Novartis Underweight | JP Morgan Chase & Co. | |
| 28.04.20 | Novartis Underweight | JP Morgan Chase & Co. | |
| 24.04.20 | Novartis Underweight | JP Morgan Chase & Co. | |
| 07.04.20 | Novartis Underweight | JP Morgan Chase & Co. | |
| 24.03.20 | Novartis Underweight | JP Morgan Chase & Co. | |
| 17.03.20 | Novartis Underweight | Barclays Capital | |
| 25.02.20 | Novartis Underweight | Barclays Capital | |
| 29.01.20 | Novartis Underweight | JP Morgan Chase & Co. | |
| 27.01.20 | Novartis Underweight | JP Morgan Chase & Co. | |
| 20.01.20 | Novartis Underweight | JP Morgan Chase & Co. | |
| 16.01.20 | Novartis Underweight | JP Morgan Chase & Co. | |
| 16.01.20 | Novartis Underweight | Barclays Capital | |
| 06.01.20 | Novartis verkaufen | Morgan Stanley | |
| 06.01.20 | Novartis Underweight | JP Morgan Chase & Co. | |
| 16.12.19 | Novartis Underweight | JP Morgan Chase & Co. | |
| 06.12.19 | Novartis Underweight | JP Morgan Chase & Co. | |
| 18.11.19 | Novartis Underweight | JP Morgan Chase & Co. | |
| 30.10.19 | Novartis Underweight | JP Morgan Chase & Co. | |
| 25.10.19 | Novartis Underweight | Barclays Capital | |
| 23.10.19 | Novartis Underweight | Barclays Capital | |
| 23.10.19 | Novartis Underweight | JP Morgan Chase & Co. | |
| 22.10.19 | Novartis Underweight | Morgan Stanley | |
| 22.10.19 | Novartis Underweight | JP Morgan Chase & Co. | |
| 21.10.19 | Novartis Underweight | Morgan Stanley | |
| 18.10.19 | Novartis Underweight | JP Morgan Chase & Co. | |
| 17.10.19 | Novartis Underweight | JP Morgan Chase & Co. | |
| 07.10.19 | Novartis Underweight | JP Morgan Chase & Co. | |
| 04.10.19 | Novartis Underweight | JP Morgan Chase & Co. | |
| 09.09.19 | Novartis Underweight | JP Morgan Chase & Co. | |
| 05.09.19 | Novartis Underweight | Barclays Capital | |
| 28.08.19 | Novartis Underweight | JP Morgan Chase & Co. | |
| 29.07.19 | Novartis Underweight | JP Morgan Chase & Co. | |
| 24.07.19 | Novartis Underweight | JP Morgan Chase & Co. | |
| 19.07.19 | Novartis Underweight | Barclays Capital | |
| 16.07.19 | Novartis Underweight | JP Morgan Chase & Co. | |
| 05.07.19 | Novartis Underweight | JP Morgan Chase & Co. | |
Werbung
Werbung